Introduction
Pediatric malignancies occupy 5% of total cancer burden in India with 45,000 new cases registered yearly. [1] The standardized incidence rate for India ranged from 38 to 124 per million children per year compared to 75-150 per million worldwide. [2] Although cure rates of childhood malignancies exceed beyond 80% in Western countries, however, this golden milestone remains elusive in lower and middle income countries where 80% of children live worldwide. [2] Even in India, there is gross disparity between outcomes of childhood cancers reported by apex pediatric comprehensive cancer center like Tata Memorial Hospital, Mumbai, and centers in other urban population-based cancer registries (PBCRs) where outcomes drop by half. [3] [4] [5] In the absence of PBCR and lack of dedicated pediatric oncology centers, the profile of childhood cancers in most populous east Indian states of Uttar Pradesh and Bihar is lacking. We attempt to provide first comprehensive consecutive individual pediatric cancer data registered in 1 year in our tertiary government hospital/regional cancer center of Bihar.
Materials and Methods
Our center is the only regional cancer center of State Government catering the need of 120 million populations residing in Bihar. The Department of Medical and Pediatric Oncology of our Institute is the major primary referral unit for several childhood cancers diagnosed in any hospital/clinic across the state, including cases referred by allied specialties in the adjacent tertiary care hospital. All individual consecutive children diagnosed with any malignancy between ages 0 and 18 years and registered in our department from January 1, 2018 to January 31, 2018 were enrolled in this study. Demographic data with respect to age, sex, symptoms, and diagnosis were collected. Children were grouped into either with hematological malignancies or with solid tumor cancers. This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
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Pediatric and Adolescent Cancers ORIGINAL ARTICLE sarcoma group (5) , comprised of malignant fibrous histiocytoma (2), dermatofibrosarcoma protuberans (1), malignant peripheral nerve sheath tumor (1), and synovial sarcoma (1). The central nervous system malignancies were among the least common solid tumor cancers, 3/105 (3%), with one each of medulloblastoma, ependymoma, and astrocytic gliomas, respectively.
Discussion
Annually, more than 0.2 million new cases of pediatric cancers are diagnosed worldwide, of which 80% are from developing countries. [6] ALL is the most common pediatric cancer comprising 25%-30% of all childhood malignancies. [7] In Western nations, including the United State of America and Europe, ALL is closely followed by brain tumors (20%), lymphomas (12%-15%, neuroblastoma (6.5%), and Wilms' tumor (6%). [7, 8] Overall 5-year survival has reached 80% across all major pediatric cancers, with Hodgkin's lymphoma and retinoblastoma surpassing 95% in developed world. [9] In contrast to above, the demography and outcome of childhood cancers in developing world, including India is different. While ALL retains its position as the most common childhood cancer, the incidence of brain tumor is half in India compared to West, making lymphomas as the second most common malignancy. [2, 10] Among lymphomas too, Hodgkin's lymphoma exceeds over non-Hodgkin's lymphoma, with mixed cellularity more common than nodular sclerosis with peak as much younger age due to early Epstein-Barr virus exposure compared to West. [4, 11, 12] Diffuse large B-cell lymphomas and lymphoblastic lymphomas supersede Burkitts/burkitts-like lymphoma among non-Hodgkin's lymphoma contrary to West. [2, 5, 13] While neuroblastoma are reported less frequently, the incidence of retinoblastoma has been placed higher in comparison to developed world. [2, 4, 14, 15] India reports significant male preponderance which can be partially explained by skewed gender selection of cases at time of presentation rather than true gender disparity. [16] Despite data mined from PBCRs, childhood cancers in India is still under diagnosed and less ascertained to due to the lack of awareness in public and rural physicians, insufficient skills, workforce, laboratory, financial constrains coupled with lack of availability, and access to specialized pediatric cancer centers. [17] Bihar and Uttar Pradesh are the two most populous Indian states. Bihar has least per capita income and expenditure on health, with 45% of population still below the poverty line and half of the people being illiterate. [18, 19] Due to the absence of PBCR and insufficient specialized tertiary cancer centers, the exact incidence and demographic profile of cancer is unknown, especially for pediatric malignancies. We report first individual consecutive pediatric cancer data from the only Government Regional Cancer Center equipped to treat pediatric cancer in Bihar. Compared to data from other major PBCRs in India, our report too suggests ALL as the most common pediatric cancer followed by Hodgkin's lymphoma. However, in solid cancers, Wilms' tumor tops the list followed by Ewing's sarcoma and germ cell tumor. Retinoblastomas are the modest in numbers compared to other PBCRs where much higher incidence is reported.
We have very small number of central nervous system tumors, which could be partially explained by fewer well-equipped magnetic resonance imaging scanning centers with trained anesthetists to sedate children with suspected brain tumors, leading to underdiagnosis. This is further compounded by ignorance among rural primary physicians to early symptoms of brain tumor, including headache, projectile vomiting, nystagmus, gait changes, and seizures. Referral from centers lacking neurosurgical intervention in Bihar despite radiological suspicion of brain tumor may cause spill of such cases to neighboring states with better set up. Lack of expertise to refer patients after neurosurgical intervention for chemotherapy and radiotherapy in medulloblastoma, ependymomas, and gliomas apart for financial constraints may further limit their presentation in the Medical Oncology Outpatient department.
Conclusion
ALL and Hodgkin's lymphoma are the most common pediatric cancers in Bihar. Among solid malignancies, Wilms' tumor, Ewing's sarcoma, and germ cell tumor are predominant. Retinoblastomas are the modest in number compared to that reported by other population-based registries in India. The central nervous system tumors are rare, largely due to being under diagnosed with inappropriate and inadequate referral.
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There are no conflicts of interest. have been reported in the literature where either thalidomide or bortezomib-based chemotherapy has been given. [2, 7] Our first case with clinical features resembling RA, she had bilateral symmetrical swelling with tenderness in multiple joints of extremities, including MCP and PIP joints. Her RF and anti-CCP were negative, and she was treated as seronegative RA with methotrexate therapy. Following the worsening of symptoms and re-evaluation, a diagnosis of multiple myeloma with MAA was made. The second patient had symmetrical polyarthritis. Laboratory evaluation for RA was negative, and a provisional diagnosis of fibrosing tenosynovitis was made. Hematological investigations were suggestive of multiple myeloma. Synovial biopsy from the MCP joint was suggestive of amyloid deposits. Both patients had lambda light chain myeloma and responded well to bortezomib-based chemotherapy. In our patients, amyloid deposition was seen around the joints, as confirmed by synovial biopsy.
In conclusion, it is necessary to consider MAA in the differential diagnosis of patients presenting with clinical symptoms similar to that of RA or other seronegative spondyloarthropathies so that this syndrome can be made promptly diagnosed and appropriate therapy can be instituted early.
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